- Home
- PTGX vs BROS Comparison
PTGX vs BROS Comparison
Compare PTGX & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | BROS |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.6B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PTGX | BROS |
|---|---|---|
| Price | $97.01 | $55.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 20 |
| Target Price | ★ $108.23 | $76.40 |
| AVG Volume (30 Days) | 462.9K | ★ 3.8M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.24 |
| EPS | 0.05 | ★ 0.13 |
| Revenue | N/A | ★ $1,638,159,000.00 |
| Revenue This Year | $874.25 | $27.34 |
| Revenue Next Year | N/A | $23.01 |
| P/E Ratio | $2,055.80 | ★ $430.15 |
| Revenue Growth | N/A | ★ 27.88 |
| 52 Week Low | $49.86 | $44.58 |
| 52 Week High | $107.84 | $74.65 |
Technical Indicators
Market Signals| Indicator | PTGX | BROS |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 49.74 |
| Support Level | $96.36 | $50.16 |
| Resistance Level | $104.85 | $59.34 |
| Average True Range (ATR) | 4.25 | 2.36 |
| MACD | -0.26 | 0.18 |
| Stochastic Oscillator | 42.59 | 51.50 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies, and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company-operated shops.